These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 21093517)

  • 21. SF-6 attenuates 6-hydroxydopamine-induced neurotoxicity: an in vitro and in vivo investigation in experimental models of Parkinson's disease.
    Rajendra Kopalli S; Koppula S; Shin KY; Noh SJ; Jin Q; Hwang BY; Suh YH
    J Ethnopharmacol; 2012 Sep; 143(2):686-94. PubMed ID: 22902248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gallic Acid Protects 6-OHDA Induced Neurotoxicity by Attenuating Oxidative Stress in Human Dopaminergic Cell Line.
    Chandrasekhar Y; Phani Kumar G; Ramya EM; Anilakumar KR
    Neurochem Res; 2018 Jun; 43(6):1150-1160. PubMed ID: 29671234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caffeine and CSC, adenosine A2A antagonists, offer neuroprotection against 6-OHDA-induced neurotoxicity in rat mesencephalic cells.
    Nobre HV; Cunha GM; de Vasconcelos LM; Magalhães HI; Oliveira Neto RN; Maia FD; de Moraes MO; Leal LK; Viana GS
    Neurochem Int; 2010 Jan; 56(1):51-8. PubMed ID: 19782116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotective effects of neurokinin receptor one in dopaminergic neurons are mediated through Akt/PKB cell signaling pathway.
    Chu JM; Chen LW; Chan YS; Yung KK
    Neuropharmacology; 2011 Dec; 61(8):1389-98. PubMed ID: 21907219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The neuroprotective effect of Activin A and B: implication for neurodegenerative diseases.
    Kupershmidt L; Amit T; Bar-Am O; Youdim MB; Blumenfeld Z
    J Neurochem; 2007 Nov; 103(3):962-71. PubMed ID: 17680997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chlorogenic Acid Exerts Beneficial Effects in 6-Hydroxydopamine-Induced Neurotoxicity by Inhibition of Endoplasmic Reticulum Stress.
    Shan S; Tian L; Fang R
    Med Sci Monit; 2019 Jan; 25():453-459. PubMed ID: 30645211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway.
    Lou H; Jing X; Wei X; Shi H; Ren D; Zhang X
    Neuropharmacology; 2014 Apr; 79():380-8. PubMed ID: 24333330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chrysotoxine, a novel bibenzyl compound, inhibits 6-hydroxydopamine induced apoptosis in SH-SY5Y cells via mitochondria protection and NF-κB modulation.
    Song JX; Shaw PC; Sze CW; Tong Y; Yao XS; Ng TB; Zhang YB
    Neurochem Int; 2010 Nov; 57(6):676-89. PubMed ID: 20708055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease.
    Lastres-Becker I; Molina-Holgado F; Ramos JA; Mechoulam R; Fernández-Ruiz J
    Neurobiol Dis; 2005; 19(1-2):96-107. PubMed ID: 15837565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
    Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
    Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lonicera japonica THUNB. protects 6-hydroxydopamine-induced neurotoxicity by inhibiting activation of MAPKs, PI3K/Akt, and NF-κB in SH-SY5Y cells.
    Kwon SH; Hong SI; Jung YH; Kim MJ; Kim SY; Kim HC; Lee SY; Jang CG
    Food Chem Toxicol; 2012 Mar; 50(3-4):797-807. PubMed ID: 22227216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the neuroprotective potential of caffeic acid phenethyl ester in a cellular model of Parkinson's disease.
    Turan D; Abdik H; Sahin F; Avşar Abdik E
    Eur J Pharmacol; 2020 Sep; 883():173342. PubMed ID: 32634439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of 6-hydroxydopamine-induced endoplasmic reticulum stress by l-carnosine in SH-SY5Y cells.
    Oh YM; Jang EH; Ko JH; Kang JH; Park CS; Han SB; Kim JS; Kim KH; Pie JE; Shin DW
    Neurosci Lett; 2009 Jul; 459(1):7-10. PubMed ID: 19394406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tetrahydroxystilbene glucoside protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity.
    Sun FL; Zhang L; Zhang RY; Li L
    Eur J Pharmacol; 2011 Jun; 660(2-3):283-90. PubMed ID: 21497157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyruvate protects cerebellar granular cells from 6-hydroxydopamine-induced cytotoxicity by activating the Akt signaling pathway and increasing glutathione peroxidase expression.
    Fernandez-Gomez FJ; Pastor MD; Garcia-Martinez EM; Melero-Fernandez de Mera R; Gou-Fabregas M; Gomez-Lazaro M; Calvo S; Soler RM; Galindo MF; Jordán J
    Neurobiol Dis; 2006 Nov; 24(2):296-307. PubMed ID: 16978869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective effects of luteolin against apoptosis induced by 6-hydroxydopamine on rat pheochromocytoma PC12 cells.
    Guo DJ; Li F; Yu PH; Chan SW
    Pharm Biol; 2013 Feb; 51(2):190-6. PubMed ID: 23035972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
    Porritt MJ; Batchelor PE; Howells DW
    Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
    Khan MM; Ahmad A; Ishrat T; Khan MB; Hoda MN; Khuwaja G; Raza SS; Khan A; Javed H; Vaibhav K; Islam F
    Brain Res; 2010 Apr; 1328():139-51. PubMed ID: 20167206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel thiol antioxidant that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson's disease.
    Bahat-Stroomza M; Gilgun-Sherki Y; Offen D; Panet H; Saada A; Krool-Galron N; Barzilai A; Atlas D; Melamed E
    Eur J Neurosci; 2005 Feb; 21(3):637-46. PubMed ID: 15733082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leaf extract of Rhus verniciflua Stokes protects dopaminergic neuronal cells in a rotenone model of Parkinson's disease.
    Kim S; Park SE; Sapkota K; Kim MK; Kim SJ
    J Pharm Pharmacol; 2011 Oct; 63(10):1358-67. PubMed ID: 21899552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.